Supernus Pharmaceuticals (SUPN) Depreciation and Depletion (2011 - 2015)

Supernus Pharmaceuticals (SUPN) has 5 years of Depreciation and Depletion data on file, last reported at $160000.0 in Q2 2015.

• On a quarterly basis, Depreciation and Depletion fell 9.09% year-over-year to $160000.0 in Q2 2015; TTM through Jun 2015 was $670000.0, a 3.88% increase from a year earlier, with the FY2014 full-year figure at $699000.0, up 36.52% from the prior year.
• Depreciation and Depletion for Q2 2015 stood at $160000.0, up from $156000.0 in the prior quarter.
• Over the last five years, Depreciation and Depletion for SUPN reached as high as $156.0 million in Q2 2012 and fell as low as $105000.0 in Q2 2013.
• Historically, Depreciation and Depletion has averaged $9.3 million across 5 years, with a median of $164000.0 in 2012.
• Across the five-year window, Depreciation and Depletion jumped 96794.41% in 2012 and plunged 99.93% in 2013, its largest moves.
• Year by year, Depreciation and Depletion stood at $171000.0 in 2011, then dropped by 4.09% to $164000.0 in 2012, then decreased by 4.27% to $157000.0 in 2013, then gained by 8.28% to $170000.0 in 2014, then declined by 5.88% to $160000.0 in 2015.
• Per Business Quant data, the three most recent Depreciation and Depletion figures were $160000.0 in Q2 2015, $156000.0 in Q1 2015, and $170000.0 in Q4 2014.